In one of these, encompassing various types of malignancy, including a small number of breast cancer patients (n=10), elevated serum levels of GDF-15 were detected in 6/10 patients, with the median value being significantly higher than that of a much larger group of control subjects (n=260) (42). The gene discussed is GDF15; the disease is breast cancer.